Lucid Diagnostics Inc. Common Stock (LUCD) stock analysis and AI prediction
The company facts of Lucid Diagnostics Inc. Common Stock, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Lucid Diagnostics Inc. Common Stock
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $79.5 million
- Size
- Micro cap
- Employees
- 82
- Headquarters
- NEW YORK, NY
- Listed since
- Oct. 14, 2021
- Website
- luciddx.com
More Healthcare stocks
Other micro cap stocks
Keep going
LUCD questions
What is the AI prediction for LUCD stock?
Each market day our model rates Lucid Diagnostics Inc. Common Stock (LUCD) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the LUCD prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for LUCD?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see LUCD options?
The LUCD options page opens its calls and puts, with price, volume, implied volatility and the Greeks.